Lasmiditan Succinate Tablet — FDA Drug Shortage

No longer listed by FDA — Eli Lilly And Co.

The FDA lists a drug shortage record for Lasmiditan Succinate Tablet (tablet) from Eli Lilly And Co. with status No longer listed by FDA. The shortage was first posted on Nov 3, 2025.

Shortage details

Status
No longer listed by FDA
Company
Eli Lilly And Co.
Package NDC
0002-4491-61
Dosage Form
Tablet
Presentation
Reyvow, Tablet, 100 mg (NDC 0002-4491-61)
Initial Posting
Nov 3, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.